林 毓志

Medicine & Life Sciences

1. Premature Infants 100%
2. Dexamethasone 56%
3. Very Low Birth Weight Infant 53%
4. Newborn Infant 36%
5. Gestational Age 22%
6. Lung Diseases 19%
7. Respiratory Distress Syndrome In Premature Infants 18%
8. Bronchopulmonary Dysplasia 18%
9. Neonatal Intensive Care Units 17%
10. Parturition 17%
11. Lung 17%
12. Newborn Respiratory Distress Syndrome 17%
13. Birth Weight 16%
14. Patent Ductus Arteriosus 16%
15. Extremely Low Birth Weight Infant 15%
16. Secondary Prevention 15%
17. Pneumonia 15%
18. Hospitalization 15%
19. Mortality 13%
20. Chronic Disease 13%
21. Artificial Respiration 12%
22. Therapeutics 12%
23. Hypoglycemia 12%
24. Respiratory Syncytial Viruses 11%
25. Growth 10%
26. Pulmonary Hypertension 10%
27. Incidence 10%
28. Bilirubin 10%
29. Retinopathy of Prematurity 10%
30. Morbidity 10%
31. Nitric Oxide 8%
32. Branchioma 8%
33. Palivizumab 8%
34. Congenital Hyperinsulinism 8%
35. Length of Stay 8%
36. Body Weight 8%
37. Meconium Aspiration Syndrome 7%
38. Ebstein Anomaly 7%
39. Pulmonary Surfactant-Associated Protein D 7%
40. Randomized Controlled Trials 7%
41. Control Groups 7%
42. Prostaglandins 7%
43. Foramen Magnum 7%